These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 22990325)
1. Allicin ameliorates cardiac hypertrophy and fibrosis through enhancing of Nrf2 antioxidant signaling pathways. Li XH; Li CY; Xiang ZG; Hu JJ; Lu JM; Tian RB; Jia W Cardiovasc Drugs Ther; 2012 Dec; 26(6):457-65. PubMed ID: 22990325 [TBL] [Abstract][Full Text] [Related]
2. Allicin protects against cardiac hypertrophy and fibrosis via attenuating reactive oxygen species-dependent signaling pathways. Liu C; Cao F; Tang QZ; Yan L; Dong YG; Zhu LH; Wang L; Bian ZY; Li H J Nutr Biochem; 2010 Dec; 21(12):1238-50. PubMed ID: 20185286 [TBL] [Abstract][Full Text] [Related]
3. Chronic administration of angiotensin-(1-7) attenuates pressure-overload left ventricular hypertrophy and fibrosis in rats. Wang LJ; He JG; Ma H; Cai YM; Liao XX; Zeng WT; Liu J; Wang LC Di Yi Jun Yi Da Xue Xue Bao; 2005 May; 25(5):481-7. PubMed ID: 15897115 [TBL] [Abstract][Full Text] [Related]
4. Allicin ameliorates cognitive deficits ageing-induced learning and memory deficits through enhancing of Nrf2 antioxidant signaling pathways. Li XH; Li CY; Lu JM; Tian RB; Wei J Neurosci Lett; 2012 Apr; 514(1):46-50. PubMed ID: 22390900 [TBL] [Abstract][Full Text] [Related]
5. Parthenolide inhibits STAT3 signaling and attenuates angiotensin II-induced left ventricular hypertrophy via modulation of fibroblast activity. Skoumal R; Tóth M; Serpi R; Rysä J; Leskinen H; Ulvila J; Saiho T; Aro J; Ruskoaho H; Szokodi I; Kerkelä R J Mol Cell Cardiol; 2011 Apr; 50(4):634-41. PubMed ID: 21223972 [TBL] [Abstract][Full Text] [Related]
6. Effects of Allicin on Hypertension and Cardiac Function in Chronic Kidney Disease. García-Trejo EM; Arellano-Buendía AS; Argüello-García R; Loredo-Mendoza ML; García-Arroyo FE; Arellano-Mendoza MG; Castillo-Hernández MC; Guevara-Balcázar G; Tapia E; Sánchez-Lozada LG; Osorio-Alonso H Oxid Med Cell Longev; 2016; 2016():3850402. PubMed ID: 27990229 [TBL] [Abstract][Full Text] [Related]
7. [Mechanism of cardiac function changes in rat models of Sjogren's syndrome based on Keap1-Nrf2/ARE signaling pathways]. Wang F; Liu J; Ye Y; Zhang X; Wan L Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 May; 30(5):497-501. PubMed ID: 24796746 [TBL] [Abstract][Full Text] [Related]
8. Chronic blockade of class I PI3-kinase attenuates Ang II-induced cardiac hypertrophy and autophagic alteration. Yan W; Guo LR; Zhang Q; Sun WZ; O'Rourke ST; Liu KX; Sun CW Eur Rev Med Pharmacol Sci; 2015; 19(5):772-83. PubMed ID: 25807429 [TBL] [Abstract][Full Text] [Related]
9. Nuclear factor-kappaB signaling contributes to severe, but not moderate, angiotensin II-induced left ventricular remodeling. Sármán B; Skoumal R; Leskinen H; Rysä J; Ilves M; Soini Y; Tuukkanen J; Pikkarainen S; Lakó-Futó Z; Sármán B; Papp L; deChâtel R; Tóth M; Ruskoaho H; Szokodi I J Hypertens; 2007 Sep; 25(9):1927-39. PubMed ID: 17762659 [TBL] [Abstract][Full Text] [Related]
10. Baicalein attenuates angiotensin II-induced cardiac remodeling via inhibition of AKT/mTOR, ERK1/2, NF-κB, and calcineurin signaling pathways in mice. Wang AW; Song L; Miao J; Wang HX; Tian C; Jiang X; Han QY; Yu L; Liu Y; Du J; Xia YL; Li HH Am J Hypertens; 2015 Apr; 28(4):518-26. PubMed ID: 25362112 [TBL] [Abstract][Full Text] [Related]
11. Proteasome inhibition attenuates heart failure during the late stages of pressure overload through alterations in collagen expression. Ma Y; Chen Y; Yang Y; Chen B; Liu D; Xiong Z; Zhang C; Dong Y Biochem Pharmacol; 2013 Jan; 85(2):223-33. PubMed ID: 23142711 [TBL] [Abstract][Full Text] [Related]
12. Adiponectin ameliorates hyperglycemia-induced cardiac hypertrophy and dysfunction by concomitantly activating Nrf2 and Brg1. Li H; Yao W; Irwin MG; Wang T; Wang S; Zhang L; Xia Z Free Radic Biol Med; 2015 Jul; 84():311-321. PubMed ID: 25795513 [TBL] [Abstract][Full Text] [Related]
13. Early onset of chondroitin sulfate and osteopontin expression in angiotensin II-dependent left ventricular hypertrophy. Rothermund L; Kreutz R; Kossmehl P; Fredersdorf S; Shakibaei M; Schulze-Tanzil G; Paul M; Grimm D Am J Hypertens; 2002 Jul; 15(7 Pt 1):644-52. PubMed ID: 12118914 [TBL] [Abstract][Full Text] [Related]
14. Differential role of TIMP2 and TIMP3 in cardiac hypertrophy, fibrosis, and diastolic dysfunction. Fan D; Takawale A; Basu R; Patel V; Lee J; Kandalam V; Wang X; Oudit GY; Kassiri Z Cardiovasc Res; 2014 Jul; 103(2):268-80. PubMed ID: 24692173 [TBL] [Abstract][Full Text] [Related]
15. Allicin ameliorates obesity comorbid depressive-like behaviors: involvement of the oxidative stress, mitochondrial function, autophagy, insulin resistance and NOX/Nrf2 imbalance in mice. Gao W; Wang W; Zhang J; Deng P; Hu J; Yang J; Deng Z Metab Brain Dis; 2019 Oct; 34(5):1267-1280. PubMed ID: 31201726 [TBL] [Abstract][Full Text] [Related]
16. [Astragalus polysaccharides improved the cardiac function in Sjögren's syndrome model rats based on keap 1-Nrf2/ARE signaling pathway: a mechanism exploration]. Wang F; Lui J; Ye YF; Zhang XJ; Wan L; Li Z Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 May; 34(5):566-74. PubMed ID: 24941846 [TBL] [Abstract][Full Text] [Related]
18. Azilsartan ameliorates ventricular hypertrophy in rats suffering from pressure overload-induced cardiac hypertrophy by activating the Keap1-Nrf2 signalling pathway. Hou N; Li LR; Shi YY; Yuan WC; Zhao GJ; Liu XW; Cai SA; Huang Y; Zhan HX; Pan WB; Luo CF J Pharm Pharmacol; 2021 Dec; 73(12):1715-1725. PubMed ID: 34343333 [TBL] [Abstract][Full Text] [Related]
19. Synergetic antioxidant and vasodilatory action of carbon monoxide in angiotensin II - induced cardiac hypertrophy. Kobayashi A; Ishikawa K; Matsumoto H; Kimura S; Kamiyama Y; Maruyama Y Hypertension; 2007 Dec; 50(6):1040-8. PubMed ID: 17923586 [TBL] [Abstract][Full Text] [Related]
20. Comparison of extracts from cooked and raw lentil in antagonizing angiotensin II-induced hypertension and cardiac hypertrophy. Xuan CL; Yao FR; Guo LR; Liu Q; Chang SK; Liu KX; Sun CW Eur Rev Med Pharmacol Sci; 2013 Oct; 17(19):2644-53. PubMed ID: 24142613 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]